Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer [Phase 2]

View source ↗

Summary

Clinical trial update describes a Phase 2 study evaluating the combination of iparomlimab and tuvonralimab with platinum-based chemotherapy as neoadjuvant thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Shandong Tumor Hospital | Conditions: Cervical Cancer, Neoadjuvant Therapy | Phase 2 | Status: NOT_YET_RECRUITING